You have no items in your shopping cart.
You have no items in your shopping cart.
Catalog Number | orb1479255 |
---|---|
Category | Proteins |
Description | Binds to PD-L1; Peptides. |
Form/Appearance | Freeze dried solid |
Purity | > 95% by hplc |
MW | 860.48 Da |
Formula | C33H64N16O9S |
H-Cys-Val-Arg-Ala-Arg-Thr-Arg-OH | |
Solubility (25°C) | Soluble in water |
Protein Sequence | CVRARTR |
Storage | Store dry, frozen and in the dark |
Alternative names | CVRARTR, PD-L1-blocking peptide, PD-L1Pep-2PP380 Read more... |
Background | PD-L1Pep-2 was identified from a phage-displayed library for peptides that selectively bind to PD-L1-overexpressing cells. PD-L1Pep-2 has a binding affinity of 281 nM, and preferentially binds to high PD-L1-expressing cells over low PD-L1-expressing cells, binding further enhanced by interferon-γ, an inducer of PD-L1 expression. In animal models, intravenously injected PD-L1Pep-2 efficiently targets tumour tissues, inhibits tumour growth, and increases the CD8+/FoxP3+ ratio in mice. PD-L1Pep-2 in combination with doxorubicin inhibits tumour growth more efficiently than doxorubicin alone. PD-L1Pep-2 blockade of PD-L1 reinvigorates T-cell activity and inhibits tumour growth by enhancing anti-tumour immunity. |
Note | For research use only |
Expiration Date | 12 months from date of receipt. |
Filter by Rating